Teratoma-Specific Assay Design Enables Detection of Circulating Tumor DNA in Post-chemotherapy Residual Retroperitoneal Disease

Clinical Genitourinary Cancer · Published 2026-07-03 · DOI 10.1016/j.clgc.2026.102616

Authors (9)

Willian Ito, Nicholas Bingham, Zine-Eddine Khene, Cynthia Wei, John T. Lafin, Waddah Arafat, Liwei Jia, Vitaly Margulis, Isamu Tachibana

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ito, W., Bingham, N., Khene, Z., et al. (2026). Teratoma-Specific Assay Design Enables Detection of Circulating Tumor DNA in Post-chemotherapy Residual Retroperitoneal Disease. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2026.102616

Related articles

• Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies · Clinical Genitourinary Cancer · 2026 · Cites or is cited by this article
• CT-Measured Psoas Area Predicts Urinary Incontinence Trajectories and Persistence After Robotic Prostatectomy: A 12-Month Analysis Using the 1-Hour Pad Test · Clinical Genitourinary Cancer · 2026 · Same journal
• Age at Diagnosis and Postoperative Outcomes among Men Treated for Prostate Cancer in the U.S. Military Health System · Clinical Genitourinary Cancer · 2026 · Same journal
• Circulating Tumor DNA After Radical Cystectomy as a Marker of Minimal Residual Disease in Muscle-Invasive Bladder Cancer: A Literature Review · Clinical Genitourinary Cancer · 2026 · Same journal
• Delayed Progression-Free Survival Benefit of Belzutifan Versus Everolimus in LITESPARK-005: A Reconstructed Time-to-Event Reanalysis · Clinical Genitourinary Cancer · 2026 · Same journal
• Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma · Clinical Genitourinary Cancer · 2026 · Same journal
• Evaluating Circulating DNA as a Prognostic Biomarker in Bladder Cancer Subtypes: A Preliminary Short Report · Clinical Genitourinary Cancer · 2026 · Same journal
• Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Variant Histology Bladder Cancer: A Multi-institutional Propensity Score-Matched Analysis · Clinical Genitourinary Cancer · 2026 · Same journal
• Trophoblastic-Differentiated Urothelial Carcinoma: Real-World Sequencing and Clinical Implications · Clinical Genitourinary Cancer · 2026 · Same journal
• Association Between Proto-Oncogene N-RAS Transcript Level and Overall Survival in Node-Negative Muscle-Invasive Bladder Cancer · Clinical Genitourinary Cancer · 2026 · Same journal